Literature DB >> 21292317

Dissolving microneedles for transdermal drug administration prepared by stepwise controlled drawing of maltose.

Kwang Lee1, Chang Yoel Lee, Hyungil Jung.   

Abstract

Dissolving microneedles, three-dimensional polymer structures with microscale cross-sectional dimensions, have been introduced as a means of safe transdermal drug delivery. Most dissolving microneedles have been fabricated using a traditional micro-casting method that cures biopolymers within three-dimensional mold, nevertheless, repeated molding process may cause damage to encapsulated drugs, a critical hurdle for clinical application. Here, we describe the stepwise controlled drawing technique that can directly fabricate dissolving microneedle from maltose by precise controlling the drawing time and the viscosity of the maltose. Controlled drawing shaped the particular sharp-conical microneedles of 1200 μm length with tip diameter of 60 μm, and dissolved within 20 min in-vivo after inserting to the skin. This technique surpasses the limitations of micro-casting for dissolving microneedle. Furthermore, transdermal delivery of impermeable hydrophilic molecules such as ascorbic acid-2-glucoside and niacinamide was confirmed as inhibition of cutaneous hypermelanosis. We anticipate that controlled drawing technique will be suitable to design dissolving microneedles for use in minimally invasive transcutaneous drug delivery to patients.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21292317     DOI: 10.1016/j.biomaterials.2011.01.014

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  33 in total

Review 1.  Skin permeabilization for transdermal drug delivery: recent advances and future prospects.

Authors:  Carl M Schoellhammer; Daniel Blankschtein; Robert Langer
Journal:  Expert Opin Drug Deliv       Date:  2014-01-07       Impact factor: 6.648

Review 2.  Polymeric microneedles for transdermal protein delivery.

Authors:  Yanqi Ye; Jicheng Yu; Di Wen; Anna R Kahkoska; Zhen Gu
Journal:  Adv Drug Deliv Rev       Date:  2018-01-31       Impact factor: 15.470

3.  Assessment of mechanical stability of rapidly separating microneedles for transdermal drug delivery.

Authors:  Meng Chan He; Bo Zhi Chen; Mohammad Ashfaq; Xin Dong Guo
Journal:  Drug Deliv Transl Res       Date:  2018-10       Impact factor: 4.617

4.  Development of vertical SU-8 microtubes integrated with dissolvable tips for transdermal drug delivery.

Authors:  Zhuolin Xiang; Hao Wang; Aakanksha Pant; Giorgia Pastorin; Chengkuo Lee
Journal:  Biomicrofluidics       Date:  2013-03-26       Impact factor: 2.800

Review 5.  Advances in transdermal insulin delivery.

Authors:  Yuqi Zhang; Jicheng Yu; Anna R Kahkoska; Jinqiang Wang; John B Buse; Zhen Gu
Journal:  Adv Drug Deliv Rev       Date:  2018-12-08       Impact factor: 15.470

6.  Development of Polylactic Acid and Bovine Serum Albumin-layered-coated Chitosan Microneedles Using Novel Bees Wax Mould

Authors:  Ravindra V Badhe; Deepak Adkine; Anagha Godse
Journal:  Turk J Pharm Sci       Date:  2021-06-18

Review 7.  Controlled Drug Delivery Using Microdevices.

Authors:  Sharma T Sanjay; Maowei Dou; Guanglei Fu; Feng Xu; XiuJun Li
Journal:  Curr Pharm Biotechnol       Date:  2016       Impact factor: 2.837

8.  Polyvinylpyrrolidone microneedles enable delivery of intact proteins for diagnostic and therapeutic applications.

Authors:  Wenchao Sun; Zeynep Araci; Mohammed Inayathullah; Sathish Manickam; Xuexiang Zhang; Marc A Bruce; M Peter Marinkovich; Alfred T Lane; Carlos Milla; Jayakumar Rajadas; Manish J Butte
Journal:  Acta Biomater       Date:  2013-05-03       Impact factor: 8.947

Review 9.  Microneedles for drug and vaccine delivery.

Authors:  Yeu-Chun Kim; Jung-Hwan Park; Mark R Prausnitz
Journal:  Adv Drug Deliv Rev       Date:  2012-05-01       Impact factor: 15.470

Review 10.  Microneedles for intradermal and transdermal drug delivery.

Authors:  Tuan-Mazlelaa Tuan-Mahmood; Maelíosa T C McCrudden; Barbara M Torrisi; Emma McAlister; Martin J Garland; Thakur Raghu Raj Singh; Ryan F Donnelly
Journal:  Eur J Pharm Sci       Date:  2013-05-13       Impact factor: 4.384

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.